Hepatocellular carcinoma surveillance: current practice and future directions

被引:37
作者
Ahn, Joseph C. [1 ]
Lee, Yi-Te [2 ,3 ]
Agopian, Vatche G. [4 ,5 ]
Zhu, Yazhen [2 ,3 ]
You, Sungyong [6 ,7 ]
Tseng, Hsian-Rong [2 ,3 ]
Yang, Ju Dong [6 ,8 ,9 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Univ Calif Los Angeles, Calif NanoSyst Inst, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90048 USA
[6] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA
[7] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA
[8] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, 8900 Beverly Blvd, Los Angeles, CA 90048 USA
[9] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
基金
美国国家卫生研究院;
关键词
Hepatocellular carcinoma; surveillance; cirrhosis; hepatitis B virus; alpha-fetoprotein; liquid biopsy; under-utilization; RANDOMIZED CONTROLLED-TRIAL; CONTRAST-ENHANCED ULTRASONOGRAPHY; CIRCULATING TUMOR-CELLS; CHRONIC LIVER-DISEASE; CHRONIC HEPATITIS-B; ALPHA-FETOPROTEIN; CANCER; ULTRASOUND; RISK; GUIDELINES;
D O I
10.20517/2394-5079.2021.131
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is among the leading causes of cancer incidence and mortality worldwide. Surveillance of individuals with cirrhosis or other conditions that confer a high risk of HCC development is essential for early detection and improved overall survival. Biannual ultrasonography with or without alpha-fetoprotein is widely recommended as the standard method for HCC surveillance, but it has limited sensitivity in early disease and may be inadequate in certain individuals. This review article will provide a comprehensive overview of the current landscape of HCC surveillance, including the rationale and indications for HCC surveillance, standard methods for HCC surveillance, and their strengths/limitations. Alternative surveillance methods such as the role of cross-sectional imaging, emerging circulating biomarkers, as well as the problem of under-utilization of HCC surveillance and surveillance-related harms will also be discussed in this review.
引用
收藏
页数:12
相关论文
共 95 条
[1]   Should AFP (or Any Biomarkers) Be Used for HCC Surveillance? [J].
Hager F. Ahmed Mohammed ;
Lewis R. Roberts .
Current Hepatology Reports, 2017, 16 (2) :137-145
[2]   Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases [J].
Ahn, Joseph C. ;
Connell, Alistair ;
Simonetto, Douglas A. ;
Hughes, Cian ;
Shah, Vijay H. .
HEPATOLOGY, 2021, 73 (06) :2546-2563
[3]   Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma [J].
Ahn, Joseph C. ;
Teng, Pai-Chi ;
Chen, Pin-Jung ;
Posadas, Edwin ;
Tseng, Hsian-Rong ;
Lu, Shelly C. ;
Yang, Ju Dong .
HEPATOLOGY, 2021, 73 (01) :422-436
[4]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[5]   Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action [J].
Asrani, Sumeet K. ;
Mellinger, Jessica ;
Arab, Juan P. ;
Shah, Vijay H. .
HEPATOLOGY, 2021, 73 (05) :2039-2050
[6]   An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis [J].
Atiq, Omair ;
Tiro, Jasmin ;
Yopp, Adam C. ;
Muffler, Adam ;
Marrero, Jorge A. ;
Parikh, Neehar D. ;
Murphy, Caitlin ;
McCallister, Katharine ;
Singal, Amit G. .
HEPATOLOGY, 2017, 65 (04) :1196-1205
[7]   Artificial intelligence for precision oncology: beyond patient stratification [J].
Azuaje, Francisco .
NPJ PRECISION ONCOLOGY, 2019, 3 (1)
[8]   Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients [J].
Berhane, Sarah ;
Toyoda, Hidenori ;
Tada, Toshifumi ;
Kumada, Takashi ;
Kagebayashi, Chiaki ;
Satomura, Shinji ;
Schweitzer, Nora ;
Vogel, Arndt ;
Manns, Michael P. ;
Benckert, Julia ;
Berg, Thomas ;
Ebker, Maria ;
Best, Jan ;
Dechene, Alexander ;
Gerken, Guido ;
Schlaak, Joerg F. ;
Weinmann, Arndt ;
Worns, Marcus A. ;
Galle, Peter ;
Yeo, Winnie ;
Mo, Frankie ;
Chan, Stephen L. ;
Reeves, Helen ;
Cox, Trevor ;
Johnson, Philip .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (06) :875-+
[9]   Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid [J].
Besa, Cecilia ;
Lewis, Sara ;
Pandharipande, Pari V. ;
Chhatwal, Jagpreet ;
Kamath, Amita ;
Cooper, Nancy ;
Knight-Greenfield, Ashley ;
Babb, James S. ;
Boffetta, Paolo ;
Padron, Norma ;
Sirlin, Claude B. ;
Taouli, Bachir .
ABDOMINAL RADIOLOGY, 2017, 42 (01) :179-190
[10]   GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis [J].
Best, Jan ;
Bechmann, Lars P. ;
Sowa, Jan-Peter ;
Sydor, Svenja ;
Dechene, Alexander ;
Pflanz, Kristina ;
Bedreli, Sotiria ;
Schotten, Clemens ;
Geier, Andreas ;
Berg, Thomas ;
Fischer, Janett ;
Vogel, Arndt ;
Bantel, Heike ;
Weinmann, Arndt ;
Schattenberg, Joern M. ;
Huber, Yvonne ;
Wege, Henning ;
von Felden, Johann ;
Schulze, Kornelius ;
Bettinger, Dominik ;
Thimme, Robert ;
Sinner, Friedrich ;
Schuette, Kerstin ;
Weiss, Karl Heinz ;
Toyoda, Hidenori ;
Yasuda, Satoshi ;
Kumada, Takashi ;
Berhane, Sarah ;
Wichert, Marc ;
Heider, Dominik ;
Gerken, Guido ;
Johnson, Philip ;
Canbay, Ali .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) :728-+